Novartis Ag (NVS) Gains from Equity Investments (2009 - 2026)
Novartis Ag (NVS) reported Gains from Equity Investments of $3.26 billion for Q2 2026, down 19.1% from $4.02 billion a year earlier but up 3.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Gains from Equity Investments (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Gains from Equity Investments came in at $12.75 billion, down 6.5% year-over-year; for FY2025, it was $13.97 billion, up 17.0% from FY2024.
- Gains from Equity Investments has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- By year, Gains from Equity Investments came in at $11.94 billion in FY2024, $6.96 billion in FY2022 (-71.0%) and $24.02 billion in FY2021 (+197.6%).
- Five-year quarterly Gains from Equity Investments spans a low of $1.47 billion in Q4 2022 and a high of $16.31 billion in Q4 2021.
- Year over year, Gains from Equity Investments has now declined in each of the last three quarters, with growth averaging 5.9% over the last six quarters.
- The high point for year-over-year Gains from Equity Investments in five years was Q4 2021 (growth of 676.8%); the low point was Q4 2022 (a decline of 91.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.16 billion (Q1 2026), $2.4 billion (Q4 2025) and $3.93 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.16 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.93 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |
| Jun 30, 2021 | 2.90 Bn |
| Mar 31, 2021 | 2.06 Bn |
API Access
Novartis Ag Gains from Equity Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-equity-investments", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();